AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
EFFECTS OF A 9.6-KB DELETION OF THE LDL RECEPTOR GENE (FH HELSINKI) ON STRUCTURE AND LEVELS OF MESSENGER-RNA
Authors: RODNINGEN OK TONSTAD S OSE L BERG K LEREN TP
Citation: Ok. Rodningen et al., EFFECTS OF A 9.6-KB DELETION OF THE LDL RECEPTOR GENE (FH HELSINKI) ON STRUCTURE AND LEVELS OF MESSENGER-RNA, Human mutation, 12(2), 1998, pp. 95-102
EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/
Authors: OSE L KASTELEIN JJP SCOTT R STEIN EA CAMPODONICO S ESCOBAR ID TATE AC CORSETTI L SHAHANE A MITCHEL YB MERCURI M
Citation: L. Ose et al., EFFICACY AND 6-MONTH SAFETY OF SIMVASTATIN 80 MG DAY - RESULTS FROM THE WORLDWIDE SIMVASTATIN EXPANDED DOSE PROGRAM (WSEDP)/, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(3), 1998, pp. 135-143
THE C677T MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE PREDISPOSES TO HYPERHOMOCYSTEINEMIA IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH CHOLESTYRAMINE
Authors: TONSTAD S REFSUM H OSE L UELAND PM
Citation: S. Tonstad et al., THE C677T MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE GENE PREDISPOSES TO HYPERHOMOCYSTEINEMIA IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH CHOLESTYRAMINE, The Journal of pediatrics, 132(2), 1998, pp. 365-368
CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/
Authors: DAVIGNON J HANEFELD M NAKAYA N HUNNINGHAKE DB INSULL W OSE L
Citation: J. Davignon et al., CLINICAL EFFICACY AND SAFETY OF CERIVASTATIN - SUMMARY OF PIVOTAL PHASE IIB III STUDIES/, The American journal of cardiology, 82(4B), 1998, pp. 32-39
FUNCTIONAL-MODELING OF VITAMIN RESPONSIVENESS IN YEAST - A COMMON PYRIDOXINE-RESPONSIVE CYSTATHIONINE BETA-SYNTHASE MUTATION IN HOMOCYSTINURIA
Authors: KIM CE GALLAGHER PM GUTTORMSEN AB REFSUM H UELAND PM OSE L FOLLING I WHITEHEAD AS TSAI MY KRUGER WD
Citation: Ce. Kim et al., FUNCTIONAL-MODELING OF VITAMIN RESPONSIVENESS IN YEAST - A COMMON PYRIDOXINE-RESPONSIVE CYSTATHIONINE BETA-SYNTHASE MUTATION IN HOMOCYSTINURIA, Human molecular genetics, 6(13), 1997, pp. 2213-2221
MOLECULAR-GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA IN NORWAY
Authors: LEREN TP TONSTAD S GUNDERSEN KE BAKKEN KS RODNINGEN OK SUNDVOLD H OSE L BERG K
Citation: Tp. Leren et al., MOLECULAR-GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA IN NORWAY, Journal of internal medicine, 241(3), 1997, pp. 185-194
FLOW CYTOMETRIC MEASUREMENT OF LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY VALIDATED BY DNA ANALYSIS IN DIAGNOSING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: URDAL P LEREN TP TONSTAD S LUND PK OSE L
Citation: P. Urdal et al., FLOW CYTOMETRIC MEASUREMENT OF LOW-DENSITY-LIPOPROTEIN RECEPTOR ACTIVITY VALIDATED BY DNA ANALYSIS IN DIAGNOSING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Cytometry, 30(5), 1997, pp. 264-268
HETEROZYGOSITY FOR APOLIPOPROTEIN A-I(R160L)(OSLO) IS ASSOCIATED WITHLOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND HDL-SUBCLASS LPA-I A-II BUT NORMAL LEVELS OF HDL-SUBCLASS LPA-I/
Authors: LEREN TP BAKKEN KS DAUM U OSE L BERG K ASSMANN G VONECKARDSTEIN A
Citation: Tp. Leren et al., HETEROZYGOSITY FOR APOLIPOPROTEIN A-I(R160L)(OSLO) IS ASSOCIATED WITHLOW-LEVELS OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND HDL-SUBCLASS LPA-I A-II BUT NORMAL LEVELS OF HDL-SUBCLASS LPA-I/, Journal of lipid research, 38(1), 1997, pp. 121-131
FOLLOW-UP OF HYPERCHOLESTEROLEMIC PATIENTS AFTER PARTICIPATING IN A CLINICAL-TRIAL
Authors: SVILAAS A KOLBJORNSEN O STROM E BYE P TONSTAD S OSE L
Citation: A. Svilaas et al., FOLLOW-UP OF HYPERCHOLESTEROLEMIC PATIENTS AFTER PARTICIPATING IN A CLINICAL-TRIAL, Atherosclerosis, 134(1-2), 1997, pp. 50-51
EXTENDING THE DOSING RANGE FOR SIMVASTATIN - THE EFFICACY AND SAFETY OF SIMVASTATIN 80 MG D/
Authors: OSE L CORSETTI LA TATE AC SHAHANE A MITCHEL YB
Citation: L. Ose et al., EXTENDING THE DOSING RANGE FOR SIMVASTATIN - THE EFFICACY AND SAFETY OF SIMVASTATIN 80 MG D/, Atherosclerosis, 134(1-2), 1997, pp. 131-131
SIMVASTATIN-FLUVASTATIN COMPARATIVE-STUDY - CONTINUED - REPLY
Authors: OSE L
Citation: L. Ose, SIMVASTATIN-FLUVASTATIN COMPARATIVE-STUDY - CONTINUED - REPLY, Clinical drug investigation, 12(1), 1996, pp. 57-57
SIMVASTATIN-FLUVASTATIN COMPARATIVE-STUDY - REPLY
Authors: OSE L
Citation: L. Ose, SIMVASTATIN-FLUVASTATIN COMPARATIVE-STUDY - REPLY, Clinical drug investigation, 11(6), 1996, pp. 363-364
RISK-FACTORS RELATED TO CAROTID INTIMA-MEDIA THICKNESS AND PLAQUE IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA AND CONTROL SUBJECTS
Authors: TONSTAD S JOAKIMSEN O STENSLANDBUGGE E LEREN TP OSE L RUSSELL D BONAA KH
Citation: S. Tonstad et al., RISK-FACTORS RELATED TO CAROTID INTIMA-MEDIA THICKNESS AND PLAQUE IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA AND CONTROL SUBJECTS, Arteriosclerosis, thrombosis, and vascular biology, 16(8), 1996, pp. 984-991
A COMMON MISSENSE MUTATION (C210G) IN THE LDL RECEPTOR GENE AMONG NORWEGIAN FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS
Authors: SUNDVOLD H SOLBERG K TONSTAD S RODNINGEN OK OSE L BERG K LEREN TP
Citation: H. Sundvold et al., A COMMON MISSENSE MUTATION (C210G) IN THE LDL RECEPTOR GENE AMONG NORWEGIAN FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS, Human mutation, 7(1), 1996, pp. 70-71
COLESTIPOL TABLETS IN ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: TONSTAD S OSE L
Citation: S. Tonstad et L. Ose, COLESTIPOL TABLETS IN ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Acta paediatrica, 85(9), 1996, pp. 1080-1082
SCREENING FOR KNOWN MUTATIONS IN THE LDL RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA (VOL 95, PG 671, 1995)
Authors: LEREN TP SUNDVOLD H RODNINGEN OK TONSTAD S SOLBERG K OSE L BERG K
Citation: Tp. Leren et al., SCREENING FOR KNOWN MUTATIONS IN THE LDL RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA (VOL 95, PG 671, 1995), Human genetics, 97(2), 1996, pp. 268-268
PHYTOSTEROLAEMIA IN A NORWEGIAN FAMILY - DIAGNOSIS AND CHARACTERIZATION OF THE FIRST SCANDINAVIAN CASE
Authors: LUTJOHANN D BJORKHEM I OSE L
Citation: D. Lutjohann et al., PHYTOSTEROLAEMIA IN A NORWEGIAN FAMILY - DIAGNOSIS AND CHARACTERIZATION OF THE FIRST SCANDINAVIAN CASE, Scandinavian journal of clinical & laboratory investigation, 56(3), 1996, pp. 229-240
RELATION OF TOTAL HOMOCYSTEINE AND LIPID-LEVELS IN CHILDREN TO PREMATURE CARDIOVASCULAR DEATH IN MALE RELATIVES
Authors: TONSTAD S REFSUM H SIVERTSEN M CHRISTOPHERSEN B OSE L UELAND PM
Citation: S. Tonstad et al., RELATION OF TOTAL HOMOCYSTEINE AND LIPID-LEVELS IN CHILDREN TO PREMATURE CARDIOVASCULAR DEATH IN MALE RELATIVES, Pediatric research, 40(1), 1996, pp. 47-52
THE EFFECT OF GROWTH-HORMONE ON LOW-DENSITY-LIPOPROTEIN CHOLESTEROL AND LIPOPROTEIN(A) LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA
Authors: TONSTAD S SUNDT E OSE L HAGVE TA FRUCHART JC BARD JM EDEN S
Citation: S. Tonstad et al., THE EFFECT OF GROWTH-HORMONE ON LOW-DENSITY-LIPOPROTEIN CHOLESTEROL AND LIPOPROTEIN(A) LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA, Metabolism, clinical and experimental, 45(11), 1996, pp. 1415-1421
EFFICACY AND SAFETY OF CHOLESTYRAMINE THERAPY IN PERIPUBERTAL AND PREPUBERTAL CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: TONSTAD S KNUDTZON J SIVERTSEN M REFSUM H OSE L
Citation: S. Tonstad et al., EFFICACY AND SAFETY OF CHOLESTYRAMINE THERAPY IN PERIPUBERTAL AND PREPUBERTAL CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA, The Journal of pediatrics, 129(1), 1996, pp. 42-49
EFFECT OF HOMOCYSTEINE ON COPPER ION-CATALYZED, AZO COMPOUND-INITIATED, AND MONONUCLEAR CELL-MEDIATED OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN
Authors: HALVORSEN B BRUDE I DREVON CA NYSOM J OSE L CHRISTIANSEN EN NENSETER MS
Citation: B. Halvorsen et al., EFFECT OF HOMOCYSTEINE ON COPPER ION-CATALYZED, AZO COMPOUND-INITIATED, AND MONONUCLEAR CELL-MEDIATED OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN, Journal of lipid research, 37(7), 1996, pp. 1591-1600
EFFECT OF HORMONE REPLACEMENT THERAPY ON THE SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO OXIDATION AMONG POSTMENOPAUSAL HYPERCHOLESTEROLEMIC WOMEN
Authors: NENSETER MS VOLDEN V BERG T DREVON CA OSE L TONSTAD S
Citation: Ms. Nenseter et al., EFFECT OF HORMONE REPLACEMENT THERAPY ON THE SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO OXIDATION AMONG POSTMENOPAUSAL HYPERCHOLESTEROLEMIC WOMEN, European journal of clinical investigation, 26(12), 1996, pp. 1062-1068
2 NOVEL MISSENSE MUTATIONS IN THE LDL RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA
Authors: GUNDERSEN KE SOLBERG K RODNINGEN OK TONSTAD S OSE L BERG K LEREN TP
Citation: Ke. Gundersen et al., 2 NOVEL MISSENSE MUTATIONS IN THE LDL RECEPTOR GENE CAUSING FAMILIAL HYPERCHOLESTEROLEMIA, Clinical genetics, 49(2), 1996, pp. 85-87
LOW-DOSE COLESTIPOL IN ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
Authors: TONSTAD S SIVERTSEN M AKSNES L OSE L
Citation: S. Tonstad et al., LOW-DOSE COLESTIPOL IN ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Archives of Disease in Childhood, 74(2), 1996, pp. 157-160
RESULTS OF INTENSIVE LONG-TERM TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA
Authors: RETTERSTOL K STUGAARD M GORBITZ C OSE L
Citation: K. Retterstol et al., RESULTS OF INTENSIVE LONG-TERM TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA, The American journal of cardiology, 78(12), 1996, pp. 1369-1374
Risultati: 1-25 | 26-50 | 51-58